10.1 C
Sunday, April 2, 2023

AC Immune: Dementia-Focused Swiss Biotech With A Sad History Of Failures (NASDAQ:ACIU)

Must read


I covered AC Immune (NASDAQ:ACIU) nearly two years ago, and the stock is down 70% from that time. AC Immune is a developer of medicines for Alzheimer’s disease, and it used to focus on the old abeta/tau hypothesis. In my previous article, I discussed

About the TPT service

Thanks for reading. At the Total Pharma Tracker, we offer the following:-

Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. 

For investors requiring hands-on support, our in-house experts go through our tools and find the best investible stocks, complete with buy/sell strategies and alerts.

Sign up now for our free trial, request access to our tools, and find out, at no cost to you, what we can do for you. 

Source link

- Advertisement -

More articles

Leave a Reply

- Advertisement -

Latest article

%d bloggers like this: